Search research articles
Contact Us
Filters
Showing results (1-10 of 108) with videos related to
Page
of 11
Sort By:
Biomedical Mass Spectrometry
|
February 1, 1976
A device for monitoring selected peaks in repetitively scanned mass spectra
C R Lee
Lancet (London, England)
|
September 28, 1974
Letter: Clinical trials with vitamin C
C R Lee
Methods and Findings in Experimental and Clinical Pharmacology
|
September 7, 2004
CYP2C9 genotype as a predictor of drug disposition in humans
C R Lee
Biochemical Medicine
|
June 1, 1977
Evidence for the beta-oxidation of orally administered 4-hydroxybutyrate in humans
C R Lee
Biomedical Mass Spectrometry
|
April 1, 1979
Inexpensive analog equipment for processing gas chromatography mass spectrometry data
C R Lee
Drugs
|
June 1, 1995
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy
C R Lee, D Faulds
Drugs & Aging
|
March 1, 1994
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders
C R Lee, P Benfield
Biomedical & Environmental Mass Spectrometry
|
June 15, 1988
Determination of melatonin by GC-MS: problems with solid phase extraction (SPE) columns
C R Lee, H Esnaud
Journal of Chromatography
|
June 9, 1976
Determination of urinary monohydric and dihydric phenols by gas chromatography of the acetate and TMS derivatives. 4-Dimethylaminopyridine as a catalyst for acetylation reactions
V Fell, C R Lee
Biomedical & Environmental Mass Spectrometry
|
March 1, 1988
Determination of melatonin in blood plasma, using capillary gas chromatography and electron impact medium-resolution mass spectrometry
C R Lee, H Esnaud
Page
of 11
Search research articles
Search
Showing results (1-10 of 108) with videos related to
Sort By:
Page
of 11
Biomedical Mass Spectrometry
|
February 1, 1976
A device for monitoring selected peaks in repetitively scanned mass spectra
C R Lee
Lancet (London, England)
|
September 28, 1974
Letter: Clinical trials with vitamin C
C R Lee
Methods and Findings in Experimental and Clinical Pharmacology
|
September 7, 2004
CYP2C9 genotype as a predictor of drug disposition in humans
C R Lee
Biochemical Medicine
|
June 1, 1977
Evidence for the beta-oxidation of orally administered 4-hydroxybutyrate in humans
C R Lee
Biomedical Mass Spectrometry
|
April 1, 1979
Inexpensive analog equipment for processing gas chromatography mass spectrometry data
C R Lee
Drugs
|
June 1, 1995
Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy
C R Lee, D Faulds
Drugs & Aging
|
March 1, 1994
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders
C R Lee, P Benfield
Biomedical & Environmental Mass Spectrometry
|
June 15, 1988
Determination of melatonin by GC-MS: problems with solid phase extraction (SPE) columns
C R Lee, H Esnaud
Journal of Chromatography
|
June 9, 1976
Determination of urinary monohydric and dihydric phenols by gas chromatography of the acetate and TMS derivatives. 4-Dimethylaminopyridine as a catalyst for acetylation reactions
V Fell, C R Lee
Biomedical & Environmental Mass Spectrometry
|
March 1, 1988
Determination of melatonin in blood plasma, using capillary gas chromatography and electron impact medium-resolution mass spectrometry
C R Lee, H Esnaud
Page
of 11